{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:26:19Z","timestamp":1768872379008,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cld.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T15:15:25Z","timestamp":1677424525000},"page":"225-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease\/Steatohepatitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Sarah","family":"Shalaby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zanetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Germani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Paolo Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2023.01.003_bib1","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.jhepr.2020.100192","article-title":"NAFLD and liver transplantation: disease burden, current management and future challenges","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.25003","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"24","author":"Younossi","year":"2018","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","article-title":"Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry","volume":"69","author":"Belli","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2023.01.003_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/lt.25361","article-title":"Increasing incidence of nonalcoholic steatohepatitis as an indication for liver transplantation in Australia and New Zealand","volume":"25","author":"Calzadilla-Bertot","year":"2019","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/medicina58020290","article-title":"Nash up, virus down: how the waiting list is changing for liver transplantation: a single center experience from Italy","volume":"58","author":"Ferrarese","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.cld.2023.01.003_bib11","doi-asserted-by":"crossref","first-page":"e13297","DOI":"10.1111\/ctr.13297","article-title":"Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis","volume":"32","author":"Loy","year":"2018","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/TP.0000000000002355","article-title":"Waiting list mortality and transplant rates for NASH cirrhosis when compared with cryptogenic, alcoholic, or AIH cirrhosis","volume":"103","author":"Thuluvath","year":"2019","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.cld.2023.01.003_bib13","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes","volume":"62","author":"Cholankeril","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.cld.2023.01.003_bib14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2023.01.003_bib15","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.13751","article-title":"Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries","volume":"38","author":"Holmer","year":"2018","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.cld.2023.01.003_bib16","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/lt.24507","article-title":"Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma","volume":"22","author":"Young","year":"2016","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.01.003_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","article-title":"Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis","volume":"35","author":"Kalinkovich","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677517","article-title":"NASH in lean individuals","volume":"39","author":"Younes","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000002433","article-title":"International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation","volume":"103","author":"Tsochatzis","year":"2019","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.cld.2023.01.003_bib21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/ajt.15784","article-title":"Obesity, transplantation, and bariatric surgery: an evolving solution for a growing epidemic","volume":"20","author":"Diwan","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/gutjnl-2011-300886","article-title":"Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis","volume":"61","author":"Newsome","year":"2012","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.cld.2023.01.003_bib23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/lt.25303","article-title":"Liver transplantation and bariatric surgery: timing and outcomes","volume":"24","author":"Diwan","year":"2018","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib24","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.jhepr.2020.100122","article-title":"Where does TIPS fit in the management of patients with cirrhosis?","volume":"2","author":"Garcia-Pagan","year":"2020","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jceh.2019.02.005","article-title":"Screening of cardiovascular disease in nonalcoholic fatty liver disease: whom and how?","volume":"9","author":"Choudhary","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/lt.24679","article-title":"Evaluation of coronary artery disease in potential liver transplant recipients","volume":"23","author":"Hogan","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2023.01.003_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2021.06.046","article-title":"Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation","volume":"339","author":"Zorzi","year":"2021","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.cld.2023.01.003_bib28","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1007\/s10620-019-05716-1","article-title":"Liver transplantation for nonalcoholic steatohepatitis: pathophysiology of recurrence and clinical challenges","volume":"64","author":"Samji","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2023.01.003_bib29","series-title":"Textbook of liver transplantation: a multidisciplinary approach","first-page":"373","article-title":"Renal dysfunction after liver transplantation","author":"Shalaby","year":"2022"},{"issue":"6","key":"10.1016\/j.cld.2023.01.003_bib30","doi-asserted-by":"crossref","first-page":"E606","DOI":"10.1111\/j.1399-0012.2011.01497.x","article-title":"Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more","volume":"25","author":"Park","year":"2011","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.cld.2023.01.003_bib31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.cld.2023.01.003_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41575-022-00638-2","article-title":"Sex bias in clinical trials in gastroenterology and hepatology","volume":"19","author":"Burra","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/tri.13814","article-title":"Disease-specific waitlist outcomes in liver transplantation - a retrospective study","volume":"34","author":"Nagai","year":"2021","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1432-2277.2008.00796.x","article-title":"Calcineurin inhibitor minimization protocols in liver transplantation","volume":"22","author":"Farkas","year":"2009","journal-title":"Transpl Int"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2023.01.003_bib35","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/lt.22386","article-title":"Metabolic syndrome: is immunosuppression to blame?","volume":"17","author":"Watt","year":"2011","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2023.01.003_bib36","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/TP.0000000000001913","article-title":"Everolimus is associated with less weight gain than tacrolimus 2 years after liver transplantation: results of a randomized multicenter study","volume":"101","author":"Charlton","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/TP.0000000000001438","article-title":"Use of everolimus in liver transplantation: recommendations from a working group","volume":"101","author":"De Simone","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib38","doi-asserted-by":"crossref","first-page":"e14532","DOI":"10.1111\/ctr.14532","article-title":"A\u00a0prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation","volume":"36","author":"Becchetti","year":"2022","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.dld.2017.08.022","article-title":"Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity","volume":"50","author":"van den Berg","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2023.01.003_bib42","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000001709","article-title":"Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis","volume":"101","author":"Bhati","year":"2017","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.cld.2023.01.003_bib43","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib44","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/TP.0000000000002317","article-title":"Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation","volume":"103","author":"Narayanan","year":"2019","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.cld.2023.01.003_bib45","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.mayocp.2018.06.020","article-title":"New-onset diabetes and preexisting diabetes are associated with comparable reduction in long-term survival after liver transplant: a machine learning approach","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/TP.0000000000002485","article-title":"Management of recurrent and De Novo NAFLD\/NASH after liver transplantation","volume":"103","author":"Germani","year":"2019","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cld.2023.01.003_bib47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"issue":"10019","key":"10.1016\/j.cld.2023.01.003_bib48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.2006.106021","article-title":"Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis","volume":"56","author":"Assy","year":"2007","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cld.2023.01.003_bib50","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/01.tp.0000181165.19788.95","article-title":"Rosiglitazone therapy of posttransplant diabetes mellitus","volume":"80","author":"Villanueva","year":"2005","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.cld.2023.01.003_bib51","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1600-6143.2004.00613.x","article-title":"Pioglitazone in the management of diabetes mellitus after transplantation","volume":"4","author":"Luther","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2023.01.003_bib52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cld.2023.01.003_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.21710","article-title":"Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia","volume":"15","author":"Almutairi","year":"2009","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2023.01.003_bib54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.25536","article-title":"Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease","volume":"55","author":"Reddy","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.01.003_bib56","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.01.003_bib57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/lt.24764","article-title":"Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma","volume":"23","author":"Lewin","year":"2017","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.01.003_bib58","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/TP.0000000000002043","article-title":"Liver transplantation for NASH-related hepatocellular carcinoma versus Non-NASH Etiologies of hepatocellular carcinoma","volume":"102","author":"Sadler","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2023.01.003_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050717","article-title":"Non-alcoholic fatty liver disease and extra-hepatic cancers","volume":"17","author":"Sanna","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.cld.2023.01.003_bib60","doi-asserted-by":"crossref","first-page":"e0155179","DOI":"10.1371\/journal.pone.0155179","article-title":"Spectrum of de novo cancers and predictors in liver transplantation: analysis of the scientific registry of transplant recipients database","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib61","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.31731","article-title":"De novo colorectal and pancreatic cancer in liver-transplant recipients: identifying the higher-risk populations","volume":"74","author":"Nasser-Ghodsi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.01.003_bib62","doi-asserted-by":"crossref","first-page":"101680","DOI":"10.1016\/j.bpg.2020.101680","article-title":"De novo and recurrent malignancy","volume":"46-47","author":"Shalaby","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.01.003_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOT.0000000000000499","article-title":"Long-term care of transplant recipients: de novo neoplasms after liver transplantation","volume":"23","author":"Burra","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.cld.2023.01.003_bib64","doi-asserted-by":"crossref","first-page":"100099","DOI":"10.1016\/j.jhepr.2020.100099","article-title":"Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis","volume":"2","author":"McSweeney","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cld.2023.01.003_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41687-018-0052-7","article-title":"Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review","volume":"2","author":"Kennedy-Martin","year":"2017","journal-title":"J\u00a0Patient Rep Outcomes"},{"issue":"1","key":"10.1016\/j.cld.2023.01.003_bib66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0000000000002490","article-title":"NAFLD and liver transplantation in children-working group report from the ILTS single topic conference on NAFLD","volume":"103","author":"Cananzi","year":"2019","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.cld.2023.01.003_bib67","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/liv.13655","article-title":"Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service","volume":"38","author":"Ferrarese","year":"2018","journal-title":"Liver Int"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612300003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612300003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:56Z","timestamp":1761069536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932612300003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S108932612300003X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.01.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease\/Steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}